Process-Equipment & Sanitary-Piping Contractor in South Carolina

It is the site-level document required by EU GMP Annex 1 explaining how facility design, utilities, equipment, process and monitoring combine to prevent contamination. FDA expects contamination to be controlled but does not mandate that specific document. A US site owned by a European parent will be asked for it, and it depends heavily on engineering evidence a contractor supplies rather than on quality documentation alone.

Not by simple table lookup. They are related, but the EU framework specifies conditions both at rest and in operation, with viable monitoring expectations attached that ISO 14644 particle classification does not carry. Translating a specification between the two without checking the in-operation and viable requirements is a recurring source of trouble during a parent company audit.

Not automatically. The monographs are closely aligned but not identical, and the production methods each has permitted have not always matched. A site supplying both markets should qualify its water against whichever specification is stricter for its products rather than assuming compliance with one delivers the other. That decision belongs at design stage, because it can affect generation method.

Both are accepted, and Annex 1 pushes firmly toward one or the other for Grade A operations rather than conventional open Grade A in a Grade B room. Isolators give higher assurance and lower background room requirements but less flexibility. RABS are more flexible but depend more on the surrounding environment and operator discipline. The decision must precede room design, because HVAC and transfers follow it.

Weld logs identifying each weld, welder, machine and parameters; borescope inspection records to an agreed coverage; slope and drainability verification; passivation records with chemistry, contact time and temperature; airflow visualization; and sterilization thermocouple mapping. All are straightforward to capture as work proceeds and effectively impossible to recreate afterwards, which is why retrofitting an audit trail rarely goes well.

Yes, and many do, but it should be a deliberate design decision rather than something discovered later. Serving both means building to the stricter requirement wherever the two diverge and documenting to satisfy both audiences. Retrofitting EU expectations into a facility designed only for FDA is considerably more expensive than designing for both from the start.

A comparable one. Device manufacturers typically hold ISO 13485 alongside FDA’s Quality System Regulation at 21 CFR 820, and European market access brings notified body involvement. The practical effect on process systems is similar: the engineering is largely common, and the difference shows up in documentation structure and in who is auditing it.

Not materially. Industrial electricity averaged 6.84 cents per kilowatt-hour in 2024 against a national average of 8.13 (EIA), comfortably below the midpoint. Design decisions here can follow the regulatory and process requirement rather than being pulled by energy economics, which is a genuine convenience when specifying continuously running cleanroom and water systems.

Yes. In practice that means building to the stricter of the two requirements where they diverge and producing documentation structured so both audiences can follow it. The useful step early on is establishing which specific standards the parent applies, because corporate engineering standards frequently go beyond the regulatory minimum and it is cheaper to know that before fabrication than during qualification.

Use the form on this page or call 201-450-8280. Useful inputs are the product and markets served, whether a European parent applies its own engineering standards, your barrier strategy if the product is sterile, the water grade required, and your target qualification date. If corporate standards exist, send them, because they frequently drive more of the specification than the regulations do.

They correspond approximately at defined occupancy states, but EU grades also carry microbial limits and specific at-rest and in-operation requirements that ISO classification does not. Treating them as interchangeable in a specification produces a room that satisfies one and not the other.

The facility, equipment, utilities, process, personnel, cleaning and monitoring, drawn together into a documented assessment of how contamination is prevented and detected. It is a manufacturer-owned document that engineering evidence feeds.

The specifications are closely aligned but not identical, and the production methods historically permitted have differed. A system intended for both markets is designed and tested against both monographs explicitly rather than assumed to cover both.

Annex 1 pushes strongly toward closed systems and isolators for aseptic processing, so a facility building for European supply now generally plans for an isolator. The decision changes the surrounding room classification and the whole building layout.

More than a domestic-only project would capture: full material traceability, weld records, slope and drainability verification, passivation records and commissioning data, because European inspection tends to probe the construction evidence more deeply.

The underlying lifecycle is common, and the emphasis differs. European inspection tends to focus on the contamination control strategy and the coherence of the documentation set, while FDA inspection focuses heavily on data integrity and investigation quality.

The coherence between the contamination control strategy, the facility design and the monitoring data, and whether the documentation set supports the certification decisions made. It reads the narrative rather than sampling records at random.

As one qualification whose evidence satisfies both expectations, rather than two parallel sets. Duplicating the qualification for a second market doubles the effort and creates two documents that can diverge.

European batch release rests on a named Qualified Person who certifies each batch, which places weight on the completeness and accessibility of the documentation supporting that certification. The evidence set has to serve a person, not only an audit.

The expectations are closely aligned, with both regulators focused on attributable, contemporaneous and complete records. Where they differ is in emphasis and in the specific guidance documents cited, not in the substance.

Registration and periodic inspection under the state programme, producing another documentation trail alongside the project records. On a dual-market site it simply joins an already substantial evidence set.

In designation and sometimes in detail, so a specification citing a European standard needs material procured and certified against it rather than against the nearest American equivalent. Assuming equivalence is a documentation problem waiting to appear.

It absorbs skilled mechanical trades in the region, so crew availability can drive the schedule on process projects. Committing crews at award rather than at mobilisation is the practical response.

It raises the design and documentation cost and rarely changes the construction cost much, because the physical requirements converge more than the paperwork does. The cost is in the evidence rather than in the steel.

Designing for one regulator and adapting later. Retrofitting the contamination control strategy and the construction evidence after the fact is far more expensive than building both in.